Efficacy of Short-course Blinatumomab for MRD Erradication in B-ALL

Clinical trial NCT06886074 · RECRUITING

Trial details

NCT number: NCT06886074
Sponsor: Hospital Universitario Dr. Jose E. Gonzalez
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Measurable Residual Disease (MRD)

Start date: 2025-01-02
Primary completion: 2027-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.